Medicare Enrolled

Dr. Vamsidhar Velcheti, MD

Medical Oncology · Jacksonville, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Research-focused
4500 SAN PABLO RD S, Jacksonville, FL 32224
9049532000
In practice since 2007 (18 years)
NPI: 1477744316 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Velcheti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Velcheti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Velcheti

Dr. Vamsidhar Velcheti is a medical oncology in Jacksonville, FL, with 18 years in practice. Based on federal Medicare data, Dr. Velcheti performed 179 Medicare services across 64 unique beneficiaries.

Between the years covered by Open Payments, Dr. Velcheti received a total of $947,942 from 43 pharmaceutical and/or device companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Velcheti is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ 179 Medicare services$ $947,942 industry payments

Medicare Practice Summary

Medicare Utilization ↗
179
Medicare services
Bottom 17% in FL for medical oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
64
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)129$86$550
Office visit, established patient, complex (40-54 min)50$123$745
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$947,942
Total received (2018-2024)
Avg $135,420/year across 7 years
Top 1% in FL for medical oncology
43
Companies
397
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$381,650 (40.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$357,601 (37.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161,715 (17.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$46,975 (5.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$144,628
2023
$124,862
2022
$428,718
2021
$24,470
2020
$64,892
2019
$95,278
2018
$65,095

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$434,154
Merck Sharp & Dohme LLC
$142,128
Foundation Medicine, Inc.
$70,750
AstraZeneca Pharmaceuticals LP
$42,790
Celgene Corporation
$27,679
Hikma Pharmaceuticals USA
$24,825
Amgen Inc.
$18,293
Regeneron Pharmaceuticals, Inc.
$17,284
GlaxoSmithKline, LLC.
$16,547
Merck Sharp & Dohme Corporation
$15,752
Janssen Scientific Affairs, LLC
$12,644
GENZYME CORPORATION
$11,428
Alkermes, Inc.
$10,517
Novocure Inc.
$10,311
Novartis Pharmaceuticals Corporation
$9,357
Fosun Pharma USA Inc.
$8,052
Daiichi Sankyo Inc.
$7,900
Taiho Oncology, Inc.
$6,600
Lilly USA, LLC
$6,442
Takeda Pharmaceuticals U.S.A., Inc.
$5,771
TAIHO ONCOLOGY, INC.
$5,556
F. Hoffmann-La Roche AG
$4,713
Galil Medical Inc.
$4,592
G1 Therapeutics, Inc.
$3,901
Genentech USA, Inc.
$3,859
Roche Diagnostics Corporation
$3,648
Promius Pharma LLC
$3,500
EMD Serono, Inc.
$3,150
Boehringer Ingelheim International GmbH
$2,763
Siemens Medical Solutions USA, Inc.
$2,625
AbbVie Inc.
$2,071
Genentech, Inc.
$1,612
Galvanize Therapeutics, Inc
$1,400
SANOFI US SERVICES INC.
$1,200
Bayer HealthCare Pharmaceuticals Inc.
$1,000
Gilead Sciences, Inc.
$760
Boehringer Ingelheim Pharmaceuticals, Inc.
$704
BeiGene USA, Inc.
$661
Blueprint Medicines Corporation
$594
Ipsen Biopharmaceuticals, Inc
$185
Clinigen Inc
$145
Janssen Biotech, Inc.
$55
Tempus AI, Inc
$23
Top 3 companies account for 68.3% of total payments
Associated products mentioned in payments ›
ALIMTA · ALIYA SYSTEM · ALUNBRIG · Abraxane · Alecensa · COSELA · FOUNDATIONACT · FOUNDATIONONE · FOUNDATIONONE CDX · FOUNDATIONONE LIQUID · GILOTRIF · ICEFX · IMFINZI · IMJUDO · KEYTRUDA · LIBTAYO · LUMAKRAS · LYNPARZA · Nplate · ONIVYDE · OPDIVO · Oncology · Optune Lua (NovoTTF-200T) · PROMACTA · Proleukin · RYBREVANT · Serplulimab · TAGRISSO · TECENTRIQ · Trodelvy · VISUAL-ICE · Vitrakvi · XT CDX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (40%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 1% for medical oncology in FL.

Equivalent to $529,576 per 100 Medicare services performed
Looking for a medical oncology in Jacksonville?
Compare medical oncologys in the Jacksonville area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
13
Per 100K population
1.3
County median income
$68,447
Nearest hospital
MAYO CLINIC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Velcheti is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (research-focused, top 1%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Velcheti experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Velcheti performed 129 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Velcheti receive payments from pharmaceutical companies?
Yes. Dr. Velcheti received a total of $947,942 from 43 companies across 397 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Velcheti's costs compare to other medical oncologys in Jacksonville?
Dr. Velcheti's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Velcheti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →